Showing results (101-110 of 887) with videos related to
Sort By:
Pageof 89
Blood Purification|September 11, 2002
Uremia-specific alterations in lipid metabolismChristoph Wanner, Vera KraneClinical Kidney Journal|February 13, 2019
Will the FAbry STabilization indEX make its way to everyday clinical practice?Tereza Cairns, Christoph WannerNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 21, 2021
Precision medicine in diabetic nephropathy and chronic kidney diseaseDanilo Fliser, Christoph WannerDiabetologia|August 23, 2018
SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseasesChristoph Wanner, Nikolaus MarxKidney International|February 21, 2014
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patientChristoph Wanner, Marcello Tonelli, Journal of Nephrology|February 12, 2008
Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapyFrank Breunig, Christoph WannerSeminars in Dialysis|July 17, 2008
Sympathetic overactivity--the Cinderella of cardiovascular risk factors in dialysis patientsOliver Vonend, L Christian Rump, Eberhard RitzJournal of the American Society of Nephrology : JASN|July 26, 2002
Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levelsAndrew G Bostom, Florian Kronenberg, Eberhard RitzJournal of the American Society of Nephrology : JASN|March 28, 2006
Calcium, calcium regulatory hormones, and calcimimetics: impact on cardiovascular mortalityClaus Peter Schmitt, Tobias Odenwald, Eberhard RitzContributions to Nephrology|June 11, 2011
Clinical manifestation and natural history of diabetic nephropathyEberhard Ritz, Xiao-Xi Zeng, Ivan RychlíkPageof 89